(Moscow Institute of Physics and Technology) A team of biophysicists has discovered and studied the structure of the KR2 rhodopsin under physiological conditions. This pioneering work breaks ground for a future breakthrough in optogenetics, a highly relevant area of biomedicine with applications in neurological disease treatment and more. The fundamental discovery will lead to a new instrument for efficient therapy of depression, anxiety disorders, epilepsy, and Parkinson's disease.
from EurekAlert! - Social and Behavioral Science http://bit.ly/2Wtr8td
No comments:
Post a Comment